This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

作者及其服务介绍 - 文章作者Terry Chrisomalis运营名为Biotech Analysis Central的医药服务，该服务在Seeking Alpha Marketplace上提供[1] - 该服务提供对多家医药公司的深度分析，订阅费为每月49美元，年度计划可享受3350%的折扣，价格为每年399美元[1] - 作者所属的投资小组Biotech Analysis Central拥有一个包含600多篇生物技术投资文章的资料库，以及一个包含10多只中小盘股票的投资组合模型[2] - 该服务提供实时聊天、一系列分析和新闻报道，旨在帮助医疗保健投资者做出明智决策[2] 免责声明 - 文章作者声明其未持有任何所提及公司的股票、期权或类似衍生品头寸，且在未来72小时内无此类头寸的建仓计划[3] - 文章内容仅代表作者个人观点，作者除从Seeking Alpha获得报酬外，未就本文获得其他补偿，与任何所提及公司无业务关系[3] - Seeking Alpha声明其并非持牌证券交易商、经纪商、美国投资顾问或投资银行，其分析师为第三方作者，包括可能未获任何机构或监管机构许可或认证的专业投资者和个人投资者[4]